BELLUS Health Inc. (BLU)
NASDAQ: BLU
· Real-Time Price · USD
14.74
0.00 (0.00%)
At close: Jun 28, 2023, 7:59 PM
Company Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications.
Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus.
The company was incorporated in 1993 and is based in Laval, Canada.
BELLUS Health Inc.
| Country | CA |
| IPO Date | Oct 27, 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 74 |
| CEO | Roberto Francesco Bellini |
Contact Details
Address: 275 Armand-Frappier Boulevard Laval, QC CA | |
| Website | https://www.bellushealth.com |
Stock Details
| Ticker Symbol | BLU |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001259942 |
| CUSIP Number | 07987C204 |
| ISIN Number | CA07987C2040 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Roberto Francesco Bellini | Pres, Chief Executive Officer & Director |
| Dr. Andreas Orfanos FFPM, M.B.B.Ch, MBA | Chief Operating Officer |
| Ramzi Benamar | Chief Financial Officer |
| Daniel Matthews | Director of Investor Relations & Communications |
| Dr. Catherine M. Bonuccelli M.D. | Chief Medical Officer |
| Dr. Denis Garceau | Chief Scientific Officer |
| Dr. Denis Garceau Ph.D. | Chief Scientific Officer |
| Francois Desjardins C.A., CPA, CPA, CA | Senior Vice President of Fin. |
| Sebastien Roy | Corporation Sec. |
| Tony Matzouranis | Chief Bus. Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 30, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 10, 2023 | 15-12G | Filing |
| Jun 28, 2023 | S-8 POS | Filing |
| Jun 28, 2023 | S-8 POS | Filing |
| Jun 28, 2023 | S-8 POS | Filing |
| Jun 28, 2023 | 25-NSE | Filing |
| Jun 28, 2023 | 6-K | Filing |
| Jun 28, 2023 | 6-K | Filing |
| Jun 16, 2023 | 6-K | Filing |